References
- Heney NM. Natural history of superficial bladder cancer. Prognostic features and long-term disease course. Urol Clin North Am 1992; 19: 429–33
- Shelley MD, Wilt TJ, Court J, Coles B, Kynaston H, Mason MD. Intravesical bacillus Calmette-Guerin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials. BJU Int 2004; 93: 485–90
- Sylvester RJ, van der Meijden AP, Lamm DL. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 2002; 168: 1964–70
- Hellsten S, Malmström P-U, Månsson W. State of the art---bladder cancer. National Board of Health and Welfare; 1997. Available on www. urologi.org/mars.html.
- Oosterlinck W, Lobel B, Jakse G, Malmstrom PU, Stockle M, Sternberg C. Guidelines on bladder cancer. Eur Urol 2002; 41: 105–12
- Hosmer D, Lemeshow S. Applied logistic regression1st ed. John Wiley, New York 1989
- Chow WH, Devesa SS. Underreporting and misclassification of urinary tract cancer cases on death certificates. Epidemiology 1996; 7: 517–20
- Bol MG, Baak JP, Buhr-Wildhagen S, Kruse AJ, Kjellevold KH, Janssen EA, et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. J Urol 2003; 169: 1291–4
- Busch C, Algaba F. The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems. Virchows Arch 2002; 441: 105–8
- Mikulowski P, Hellsten S. T1 G1 urinary bladder carcinoma: fact or fiction?. Scand J Urol Nephrol 2005; 39: 135–7
- Chebil G, Mikulowski P, Möller T, Månsson W. Validity audit of histopathologic reports on superficial bladder cancer. Scand J Urol Nephrol 2000; 34(Suppl 204)30
- Holmang S, Hedelin H, Anderstrom C, Holmberg E, Busch C, Johansson SL. Recurrence and progression in low grade papillary urothelial tumors. J Urol 1999; 162: 702–7
- Mansson A, Anderson H, Colleen S. Time lag to diagnosis of bladder cancer—influence of psychosocial parameters and level of health-care provision. Scand J Urol Nephrol 1993; 27: 363–9
- Sjöberg I, Perssson J, J Johansson S-E. Hälsorelaterade levnadsvanor 1980–2002. 2004. Swedish Central Bureau of Statistics
- Wallace DM, Bryan RT, Dunn JA, Begum G, Bathers S. Delay and survival in bladder cancer. BJU Int 2002; 89: 868–78
- Oosterlinck W. The management of superficial bladder cancer. BJU Int 2001; 87: 135–40
- Malmstrom PU, Thorn M, Lindblad P, Bergstrom R, Adami HO. Increasing survival of patients with urinary bladder cancer. A nationwide study in Sweden 1960–1986. Eur J Cancer 1993; 29A: 1868–72